BRCA1 and neoplasm: Indeed, a recent review [73] about sarcomas highlights how specific signatures, such as TMB (Tumor Mutational Burden), MSI (Microsatellite Instability) and deficiency, in BRCA1/2 genes could be useful biomarkers in this type of tumor.